Duke Human Vaccine Institute - Duke Vaccine and Trials Unit

Durham, North Carolina 27708

0 studies enrolling now · 9 studies all time

What they study most

Avian Influenza, Bacterial Infection, COVID-19, Clostridial Infection, Dysbiosis, Influenza, Influenza Immunisation, Multiple-drug Resistance, Pathogen Resistance, Pneumonia, Probiotic Therapy

Studies at this site

• Intravenous Fosfomycin Pharmacokinetics Study — Completed
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) — Stopped early
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) — Completed
• 2013/2017 H7N9 Prime-Boost Interval — Completed
• H1N1v Virus Challenge Study in Healthy Subjects — Completed
• Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children — Completed